These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

89 related articles for article (PubMed ID: 2941077)

  • 1. Limited proteolysis at the carboxy end modifies interactions between the subunits of Escherichia coli phosphofructokinase.
    Le Bras G; Garel JR
    Biochemistry; 1986 May; 25(9):2490-3. PubMed ID: 2941077
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A proteolyzed derivative of Escherichia coli phosphofructokinase is no longer sensitive to allosteric effectors and still shows cooperativity in substrate binding.
    Le Bras G; Garel JR
    Biochemistry; 1982 Dec; 21(26):6656-60. PubMed ID: 6218818
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Fructose 6-phosphate prevents the proteolyzed derivative of Escherichia coli phosphofructokinase from dissociation and inactivation.
    Le Bras G; Garel JR
    J Biol Chem; 1985 Nov; 260(25):13450-3. PubMed ID: 2932439
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Fructose-6-phosphate modifies the pathway of the urea-induced dissociation of the allosteric phosphofructokinase from Escherichia coli.
    Teschner W; Deville-Bonne D; Garel JR
    FEBS Lett; 1990 Jul; 267(1):96-8. PubMed ID: 2142107
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Purification and properties of the phosphofructokinase from Lactobacillus bulgaricus. A non-allosteric analog of the enzyme from Escherichia coli.
    Le Bras G; Deville-Bonne D; Garel JR
    Eur J Biochem; 1991 Jun; 198(3):683-7. PubMed ID: 1828763
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Modification of yeast phosphofructokinase by trypsin and subtilisin in the presence of effectors.
    Freyer R; Zietz H; Zietz HJ; Hofmann E
    Acta Biol Med Ger; 1978; 37(7):993-9. PubMed ID: 154818
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Role of the C-terminal region in the allosteric properties of Escherichia coli phosphofructokinase-1.
    Serre MC; Garel JR
    Eur J Biochem; 1990 May; 189(3):487-92. PubMed ID: 2140983
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pre-steady state quantification of the allosteric influence of Escherichia coli phosphofructokinase.
    Pham AS; Reinhart GD
    J Biol Chem; 2001 Sep; 276(37):34388-95. PubMed ID: 11443117
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A conformational transition involved in antagonistic substrate binding to the allosteric phosphofructokinase from Escherichia coli.
    Deville-Bonne D; Garel JR
    Biochemistry; 1992 Feb; 31(6):1695-700. PubMed ID: 1531298
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Regulatory properties of phosphofructokinase 2 from Escherichia coli.
    Kotlarz D; Buc H
    Eur J Biochem; 1981 Jul; 117(3):569-74. PubMed ID: 6456900
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Intermediates on the reassociation pathway of phosphofructokinase I from Escherichia coli.
    Teschner W; Garel JR
    Biochemistry; 1989 Feb; 28(4):1912-6. PubMed ID: 2524211
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Reversible high hydrostatic pressure inactivation of phosphofructokinase from Escherichia coli.
    Deville-Bonne D; Else AJ
    Eur J Biochem; 1991 Sep; 200(3):747-50. PubMed ID: 1833191
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Crystal structure of the complex of phosphofructokinase from Escherichia coli with its reaction products.
    Shirakihara Y; Evans PR
    J Mol Biol; 1988 Dec; 204(4):973-94. PubMed ID: 2975709
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The cooperativity and allosteric inhibition of Escherichia coli phosphofructokinase depend on the interaction between threonine-125 and ATP.
    Auzat I; Le Bras G; Garel JR
    Proc Natl Acad Sci U S A; 1994 Jun; 91(12):5242-6. PubMed ID: 8202475
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Slow ligand-induced transitions in the allosteric phosphofructokinase from Escherichia coli.
    Auzat I; Gawlita E; Garel JR
    J Mol Biol; 1995 Jun; 249(2):478-92. PubMed ID: 7783204
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Two Escherichia coli fructose-6-phosphate kinases. Preparative purification, oligomeric structure and immunological studies.
    Kotlarz D; Buc H
    Biochim Biophys Acta; 1977 Sep; 484(1):35-48. PubMed ID: 70226
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dissection of the effector-binding site and complementation studies of Escherichia coli phosphofructokinase using site-directed mutagenesis.
    Lau FT; Fersht AR
    Biochemistry; 1989 Aug; 28(17):6841-7. PubMed ID: 2531002
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tetramer-dimer equilibrium of phosphofructokinase and formation of hybrid tetramers.
    Le Bras G; Auzat I; Garel JR
    Biochemistry; 1995 Oct; 34(40):13203-10. PubMed ID: 7548084
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ordered disruption of subunit interfaces during the stepwise reversible dissociation of Escherichia coli phosphofructokinase with KSCN.
    Deville-Bonne D; Le Bras G; Teschner W; Garel JR
    Biochemistry; 1989 Feb; 28(4):1917-22. PubMed ID: 2524212
    [TBL] [Abstract][Full Text] [Related]  

  • 20. pH dependence of the kinetic properties of allosteric phosphofructokinase from Escherichia coli.
    Deville-Bonne D; Bourgain F; Garel JR
    Biochemistry; 1991 Jun; 30(23):5750-4. PubMed ID: 1828369
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.